 |
Letter from the CEOWelcome to SQI Diagnostics.
SQI's proprietary technologies enable Confidence, Profit and Growth for leading diagnostic laboratories that perform autoimmune testing. We provide laboratories the ability to simultaneously analyze multiple biomarkers, deliver accurate and quantitative patient results in less time, significantly reduce labor and increase profits...All in One Drop. We have received regulatory clearance to market our qualitative rheumatoid arthritis and celiac assays in the United States, our qualitative and quantitative rheumatoid arthritis and celiac assays in Canada, and our quantitative rheumatoid arthritis and celiac assays in the European Union. One of our key operational goals is to continue to develop and seek regulatory approval for additional tests, as we believe that expanding our “test menu” will drive adoption of our platform and products by customers. We also offer development services and manufacturing of diagnostic kits to our customers. Thank you for taking a few minutes to explore our website and to learn more about SQI's revolutionary in-vitro multiplexing diagnostic testing. We look forward to the opportunity to meet you and share the full capabilities and benefits we can deliver to your business. Sincerely, |
